Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Current and Emerging Strategies for Enhancing Antibody Delivery to the Brain
Rinie Bajracharya, Alayna C Caruso, Laura J. Vella, et al.
Pharmaceutics (2021) Vol. 13, Iss. 12, pp. 2014-2014
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

The Dawn of a New Era: Targeting the “Undruggables” with Antibody-Based Therapeutics
Linghui Qian, Xuefen Lin, Xue Gao, et al.
Chemical Reviews (2023) Vol. 123, Iss. 12, pp. 7782-7853
Closed Access | Times Cited: 65
Nanoparticle-Based Combinational Strategies for Overcoming the Blood-Brain Barrier and Blood-Tumor Barrier
Su Hyun Lim, Gi Taek Yee, Dongwoo Khang
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 2529-2552
Open Access | Times Cited: 16
Recent advances in Bio-conjugated nanocarriers for crossing the Blood-Brain Barrier in (pre-)clinical studies with an emphasis on vesicles
Alireza Poustforoosh, Mohammad Hadi Nematollahi, Hassan Hashemipour, et al.
Journal of Controlled Release (2022) Vol. 343, pp. 777-797
Closed Access | Times Cited: 41
Tau-targeting therapy in Alzheimer’s disease: critical advances and future opportunities
Yi Guo, Song Li, Linghui Zeng, et al.
Ageing and Neurodegenerative Diseases (2022) Vol. 2, Iss. 3, pp. 11-11
Open Access | Times Cited: 40
Reconsidering the role of blood-brain barrier in Alzheimer’s disease: From delivery to target
João André Sousa, Catarina Bernardes, Sara Bernardo-Castro, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 29
Amyloid-β-targeting immunotherapies for Alzheimer's disease
Yi Jin, Qiaofei Du, Mingjie Song, et al.
Journal of Controlled Release (2024) Vol. 375, pp. 346-365
Closed Access | Times Cited: 8
CD33 isoforms in microglia and Alzheimer's disease: Friend and foe
Ghazaleh Eskandari‐Sedighi, Jaesoo Jung, Matthew S. Macauley
Molecular Aspects of Medicine (2022) Vol. 90, pp. 101111-101111
Closed Access | Times Cited: 37
Origin, activation, and targeted therapy of glioma-associated macrophages
Can Xu, Menglin Xiao, Xiang Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 35
Exosome-mediated delivery platform of biomacromolecules into the brain: Cetuximab in combination with doxorubicin for glioblastoma therapy
Liuxiang Chu, Yuchen Sun, Yanyan Zhao, et al.
International Journal of Pharmaceutics (2024) Vol. 660, pp. 124262-124262
Closed Access | Times Cited: 6
Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis
Yuanke Li, Ruiying Liu, Zhen Zhao
Pharmaceutics (2025) Vol. 17, Iss. 1, pp. 109-109
Open Access
Antibody Immunotherapies for Personalized Opioid Addiction Treatment
Eric H. Rosenn, Miriam Korlansky, Shahin Benyaminpour, et al.
Journal of Pharmacology and Experimental Therapeutics (2025) Vol. 392, Iss. 4, pp. 103522-103522
Closed Access
PepH3-modified nanocarriers for delivery of therapeutics across the blood-brain barrier
Anikó Szecskó, Mária Mészáros, Beatriz Simões, et al.
Fluids and Barriers of the CNS (2025) Vol. 22, Iss. 1
Open Access
Ultrasound-mediated delivery of novel tau-specific monoclonal antibody enhances brain uptake but not therapeutic efficacy
Rinie Bajracharya, Esteban Cruz, Jürgen Götz, et al.
Journal of Controlled Release (2022) Vol. 349, pp. 634-648
Open Access | Times Cited: 18
The solute carrier SLC7A1 may act as a protein transporter at the blood-brain barrier
Magdalena Kurtyka, Frank Wessely, Sarah Bau, et al.
European Journal of Cell Biology (2024) Vol. 103, Iss. 2, pp. 151406-151406
Open Access | Times Cited: 3
A TNFR2-Specific TNF Fusion Protein With Improved In Vivo Activity
Juan Gamboa Vargas, Jennifer K. Wagner, Haroon Shaikh, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
The Tumor-Derived Exosomes Enhanced Bevacizumab across the Blood–Brain Barrier for Antiangiogenesis Therapy against Glioblastoma
Liuxiang Chu, Yuchen Sun, Xiaohu Tang, et al.
Molecular Pharmaceutics (2024)
Closed Access | Times Cited: 2
Targeting cerebral diseases with enhanced delivery of therapeutic proteins across the blood-brain barrier
Yanning Bao, Weiyue Lu
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 12, pp. 1681-1698
Closed Access | Times Cited: 6
The Glioblastoma Landscape: Hallmarks of Disease, Therapeutic Resistance, and Treatment Opportunities
Jack Boylan, Elizabeth Byers, Deborah F. Kelly
Medical Research Archives (2023) Vol. 11, Iss. 6
Open Access | Times Cited: 4
Chitosan-Tricarbocyanine-Based Nanogels Were Able to Cross the Blood–Brain Barrier Showing Its Potential as a Targeted Site Delivery Agent
Emilio Rivera López, Cecilia Samaniego López, Carla Spagnuolo, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 964-964
Open Access | Times Cited: 1
Revolutionizing Neuroimmunology: Unraveling Immune Dynamics and Therapeutic Innovations in CNS Disorders
Corneliu Toader, Călin Petru Tătaru, Octavian Munteanu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 24, pp. 13614-13614
Open Access | Times Cited: 1
Recent Nanoscale Carriers for Therapy of Alzheimer's Disease: Current Strategies and Perspectives
L. Ya. Zakharova, Gulnara A. Gaynanova, Elmira A. Vasilieva, et al.
Current Medicinal Chemistry (2022) Vol. 30, Iss. 33, pp. 3743-3774
Closed Access | Times Cited: 6
Increased tau expression in theAPOE4blood-brain barrier model is associated with reduced anti-tau therapeutic antibody deliveryin vitro
Joanna M. Wasielewska, Rinie Bajracharya, Rebecca L. Johnston, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
Engineered extracellular vesicles and their promising therapeutic potential in neuropsychiatric disorders
Thomas G. Schulze, Ivana Delalle
European Neuropsychopharmacology (2022) Vol. 63, pp. 14-16
Closed Access | Times Cited: 3
A Scoping Review of Focused Ultrasound Enhanced Drug Delivery for Across the Blood–Brain Barrier for Brain Tumors
Christopher M. Young, Ariel Viña-González, Rodrigo Salmeron de Toledo Aguiar, et al.
Operative Neurosurgery (2024) Vol. 27, Iss. 5, pp. 523-532
Closed Access
Human-derived monoclonal autoantibodies as interrogators of cellular proteotypes in the brain
Matthew L. Baum, Christopher M. Bartley
Trends in Neurosciences (2024)
Open Access
Page 1 - Next Page

Scroll to top